Clinical Trials
5 trialsNCT01486368 2023-08-04
A Phase II Study of PF-03446962 in Patients With Advanced Malignant Pleural Mesothelioma
Canadian Cancer Trials Group
Phase 2 Completed
NCT01620970 2021-05-14
PF-03446962 in Relapsed or Refractory Urothelial Cancer
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Phase 2 Completed
NCT02116894 2019-03-14
REGAL-1
Duke University
Phase 1 Completed
NCT01337050 2015-10-28
Asian Phase I Study Of PF-03446962
Pfizer
Phase 1 Completed
NCT00557856 2015-10-19
A First In Patient, Study Of Investigational Drug PF-03446962 In Patients With Advanced Solid Tumors
Pfizer
Phase 1 Completed